| 000 | 01917 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513130427.0 | ||
| 264 | 0 | _c19971204 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a1074-3022 | ||
| 024 | 7 |
_a10.1002/lt.500020602 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFraser, G M | |
| 245 | 0 | 0 |
_aLong-term immunosuppression without corticosteroids after orthotopic liver transplantation: a positive therapeutic aim. _h[electronic resource] |
| 260 |
_bLiver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society _cNov 1996 |
||
| 300 |
_a411-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGraft Rejection _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xadverse effects |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aLiver Transplantation _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xetiology |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aGrammoustianos, K | |
| 700 | 1 | _aReddy, J | |
| 700 | 1 | _aRolles, K | |
| 700 | 1 | _aDavidson, B | |
| 700 | 1 | _aBurroughs, A K | |
| 773 | 0 |
_tLiver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society _gvol. 2 _gno. 6 _gp. 411-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/lt.500020602 _zAvailable from publisher's website |
| 999 |
_c9317386 _d9317386 |
||